Leipzig, Germany
Professor of Medicine
Director of Angiology
University Hospital Leipzig
SCHEDULE FOR VEITHsymposium™
Tuesday, November 14, 2017
Wednesday, November 15, 2017
Presenter
2-Year Value Of The Lutonix DCB (Bard) For the Treatment Of Fem-Pop Occlusive Lesions In A RCT vs. POBA: Do The Benefits Persist And What Are They In Long Complex Lesions
11:08 AM - 11:13 AM

View Slides in PDF

Presenter
1-Year Results With The Ranger DCB (Boston Scientific) For The Treatment Of Fem-Pop Lesions: Equivalent Benefits In Diabetic Patients And 12-Month All Comer Registry Data
11:20 AM - 11:25 AM

View Slides in PDF

Presenter
DCBs And DESs Produce Equivalent Results At 2-3 Years With Short SFA Lesions But DESs Are Better For Long Lesions: From The REAL-PTX RCT
11:50 AM - 11:55 AM

View Slides in PDF

 
previous next